2/24
🎯 The rationale of #LAAO
🔸 In non-valvular #AF patients, 90% of thrombus is located in the #LAA
🔸 These thrombi embolise to the 🧠 & cause #stroke
🎯 Don't miss the ‘#EHRA_ESC#EAPCI expert consensus document on catheter-based #LAAO –an update’ doi.org/10.1093/europa…
3/24 #LAA closure devices should be safe, efficent and easy to deploy.
📌 Currently available catheter-based devices for #LAAO have different principles.
6/24 Persistent large (≥5 mm) peri-device leaks detected w/ post-procedural imaging deserve long-term #OAC or a second occlusion attempt.
🎯 As an alternative strategy, this case shows successful percutaneous leak closure w/ an Amplatzer Vascular Plug II doi.org/10.1093/ehjcr/…
7/24
📌 Imaging w/ #TEE is essential during transseptal puncture.
📌 For most #LAA, where the body is superior-anterior directed, a standard infer-posterior puncture of the fossa ovalis is recommended to provide a direct vector towards the superior-anterior LAA.
8/24 #LAAO is still possibile in patients w/ a previous atrial septal device.
📌 In this case report you will find out how #LAAO was performed w/ a LAmbre device in a patient w/ previously implanted #PFO occluder. doi.org/10.1093/ehjcr/…
9/24
📌 Pericardial tamponade rates during the #LAAO is ~ 1 %.
👉 This case shows cardiac tamponade due to high PSI injection during #LAA angiography and sealing the perforation w/ Watchman device. doi.org/10.1093/ehjcr/…
10/24 #yesCT#TEE & fluoroscopic measurements for the appropriate size of Amulet device:
15/24
🎯 Before release, 5️⃣ signs of device stability need to be verified.
1️⃣ Slightly compressed ‘lobe’
2️⃣ Orientation between the ‘lobe’ and #LAA orifice
3️⃣ Concave shaped ‘disc’
4️⃣ Separated ‘disc’ & ‘lobe’
5️⃣ The midpoint of the ‘lobe’ should be distal to the LCx.
16/24
⁉️ Despite all efforts, embolisation of the device can still occur.
🎯 In this case report, the embolised #LAAO device was retrieved using a double snaring technique.
🎯 The results of PRAGUE-17 trial, which compares NOACs w/ #LAAO in high-risk #AF patients (CHA2DS2-VASC ≥3), showed #LAAO was non-inferior to NOACs in preventing major AF-related cardiovascular, neurological, and bleeding events.
2. It’s cardiac amyloidosis! Here is a great resource from @escardio WG on Myocardial and Pericardial Diseases to start with doi.org/10.1093/eurhea…
3. First, what is amyloidosis?
Amyloidosis occurs when abnormal proteins misfold and deposit in tissues as beta-pleated sheets. These disrupt tissue structure and can cause damage to many different organs.
3/24
Honeycomb-like structure, a rare cause of myocardial ischaemia has multiple communicating channels divided by thin septa. Angiographically fuzzy & hazy appearance often without significant stenosis, they're best detected on high-resolution IVUS/OCT academic.oup.com/ehjcr/article/…